Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The protein encoded by SCARB2 is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Zusätzlich bieten wir Ihnen SCARB2 Antikörper (77) und SCARB2 Kits (11) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 16 products:
This work describes a novel function for the Scarb2 receptor as an essential glycoprotein for notochord development.
Crystal structure of a LIMP-2 luminal domain dimer with bound cholesterol and phosphatidylcholine is described. Binding of these lipids alters LIMP-2 from functioning as a glucocerebrosidase-binding monomer toward a dimeric state that preferentially binds anionic phosphatidylserine over neutral phosphatidylcholine.
The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection.
The findings identify SR-BII as a functional SAA (zeige SAA1 Proteine) receptor that mediates SAA (zeige SAA1 Proteine) uptake and contributes to its proinflammatory signaling via the MAPK (zeige MAPK1 Proteine)-mediated signaling pathways.
In this paper we provide an updated overview of the clinical and genetic features of SCARB2-related PME (zeige CSTB Proteine) and on the functions of the LIMP2 protein [review]
neutrophils are able to drive a macrophage activation that would regulate the increase in LIMP-2 expression during the early phase of Cer (zeige CBLN1 Proteine)-induced acute pancreatitis
Findings suggested that STX1B (zeige STX1B Proteine) rs4889603, FAM47E rs6812193 and SCARB2 rs6825004 do not confer a significant risk for Parkinson's disease
LIMPII was increased greater than twofold in urinary microvesicles obtained from patients with idiopathic membranous nephropathy compared to microvesicles of patients with idiopathic focal segmental glomerulosclerosis and normal controls.
hSR-BII (zeige CACNA1E Proteine), and to a lesser extent hSR-BI, significantly increase LPS (zeige IRF6 Proteine)-induced inflammation and contribute to LPS (zeige IRF6 Proteine)-induced tissue injury in the liver and kidney, two major organs susceptible to LPS (zeige IRF6 Proteine) toxicity.
Although hrGCase cellular uptake is independent of LIMP-2, its trafficking to the lysosomes is mediated by this receptor.
SNCA and SCARB2 loci are also associated with dementia with Lewy bodies, after a study-wise Bonferroni correction, although these have a different association profile than the associations reported for the same loci in Parkinson's.
LIMP-2 facilitates transport of phospholipids into murine fibroblasts, with a strong substrate preference for phosphatidylserine.
AP-3 (zeige AP3B1 Proteine)-dependent LB targeting is facilitated by protein/protein interaction between LIMP-2/SCARB2 and PRDX6 (zeige PRDX6 Proteine) in vitro and in vivo
Heterologous expression of the luminal domain of LIMP-2 in wild-type cells.
In LIMP-2-deficient brains a significant reduction in GC activity led to lipid storage, disturbed autophagic/lysosomal function, and alpha-synuclein accumulation.
absence of Limp-2 reduces inflammation in experimental crescentic glomerulonephritis with decreased macrophage and T-cell infiltration in the kidney.
Limp-2 deficiency leads to a minor increase in circulating renin (zeige REN Proteine). Limp-2, however, is not required for acute or chronic stimulation of renin (zeige REN Proteine) release.
The SR-BII is involved in cholesterol ester uptake for steroidogenesis and spermatogenesis in the testis.
The residues between 144 and 151 are critical for SCARB2 binding to VP1 of EV71 and seven residues from the human receptor could convert murine SCARB2, an otherwise inefficient receptor, to an efficient receptor for EV71 viral infection.
The data suggest that tubular proteinuria in Limp-2(-/-) mice is due to failure of endosomes containing reabsorbed proteins to fuse with lysosomes in the proximal tubule of the kidney. Failure of proteolysis is a novel mechanism for tubular proteinuria.
The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2
, CD36 antigen-like 2
, lysosome membrane protein 2
, scavenger receptor class B, member 2
, lysosome membrane protein 2-like
, putative lysosomal integral membrane protein II
, 85 kDa lysosomal membrane sialoglycoprotein
, 85 kDa lysosomal sialoglycoprotein scavenger receptor class B, member 2
, CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II)
, LIMP II
, lysosome membrane protein II